Prophylactic Intravenous Metoclopramide Use in Patients Given Intravenous Tramadol: A Retrospective Cross-Sectional Study [TRAMAX STUDY]

Abstract: The routine use of Intravenous prophylactic antiemetics with Intravenous opioid analgesics is common practice in the Emergency & Trauma Department (ETD) of Hospital Tuanku Ampuan Najihah (HTAN) to prevent opioid-induced nausea and vomiting. However, this practice has dubious clinical benefits, generates additional costs, and might expose patients to potentially adverse effects. Approximately 6000 ampules of IV Metoclopramide are used by ETD HTAN annually. The sum seems ignorable, but in 10 years, this may total over RM1,000,000. The study aimed to evaluate the benefit of intravenous metoclopramide prophylaxis in patients receiving intravenous tramadol for acute pain relief. A retrospective cross-sectional study was conducted at the ETD of HTAN using convenient sampling. Patient details were extracted from the medical record via standardized data collection form and analysed with the Statistical Package for Social Sciences version 25. A total of 272 patients were included, half of whom were given intravenous Metoclopramide prophylactically. The overall incidence of nausea in the study population was 12.1%, with most cases rated mild. Only two patients (0.7%) in the metoclopramide group vomited within 2 hours of intravenous tramadol administration, which did not demonstrate a statistically significant association between metoclopramide prophylaxis and reduced emesis episode (P= 0.498, Fisher's exact test). The low incidence of nausea and vomiting does not warrant the prophylactic use of intravenous Metoclopramide in tramadol-treated patients, suggesting a need to educate ETD medical officers on the findings to implement change in the routine prescribing practice in HTAN and subsequent cluster hospitals. Keywords: metoclopramide, tramadol, nausea, vomiting, emesis, prophylaxis. Title: Prophylactic Intravenous Metoclopramide Use in Patients Given Intravenous Tramadol: A Retrospective Cross-Sectional Study [TRAMAX STUDY] Author: Keerthy Venthen Krishna Kumar, Yu Xin Tan, Pavithrah Asogan International Journal of Healthcare Sciences ISSN 2348-5728 (Online) Vol. 13, Issue 1, April 2025 - September 2025 Page No: 44-48 Research Publish Journals Website: www.researchpublish.com Published Date: 23-April-2025 DOI: https://doi.org/10.5281/zenodo.15267834 Paper Download Link (Source) https://www.researchpublish.com/papers/prophylactic-intravenous-metoclopramide-use-in-patients-given-intravenous-tramadol-a-retrospective-cross-sectional-study-tramax-study

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-23
DOI
https://doi.org/10.5281/zenodo.15267834
Primary Topic
Nausea and vomiting management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prophylactic Intravenous Metoclopramide Use in Patients Given Intravenous Tramadol: A Retrospective Cross-Sectional Study [TRAMAX STUDY]

Zenodo (CERN European Organization for Nuclear Research)
Nausea and vomiting management
article

Prophylactic Intravenous Metoclopramide Use in Patients Given Intravenous Tramadol: A Retrospective Cross-Sectional Study [TRAMAX STUDY]

article en

Abstract

Abstract: The routine use of Intravenous prophylactic antiemetics with Intravenous opioid analgesics is common practice in the Emergency & Trauma Department (ETD) of Hospital Tuanku Ampuan Najihah (HTAN) to prevent opioid-induced nausea and vomiting. However, this practice has dubious clinical benefits, generates additional costs, and might expose patients to potentially adverse effects. Approximately 6000 ampules of IV Metoclopramide are used by ETD HTAN annually. The sum seems ignorable, but in 10 years, this may total over RM1,000,000. The study aimed to evaluate the benefit of intravenous metoclopramide prophylaxis in patients receiving intravenous tramadol for acute pain relief. A retrospective cross-sectional study was conducted at the ETD of HTAN using convenient sampling. Patient details were extracted from the medical record via standardized data collection form and analysed with the Statistical Package for Social Sciences version 25. A total of 272 patients were included, half of whom were given intravenous Metoclopramide prophylactically. The overall incidence of nausea in the study population was 12.1%, with most cases rated mild. Only two patients (0.7%) in the metoclopramide group vomited within 2 hours of intravenous tramadol administration, which did not demonstrate a statistically significant association between metoclopramide prophylaxis and reduced emesis episode (P= 0.498, Fisher's exact test). The low incidence of nausea and vomiting does not warrant the prophylactic use of intravenous Metoclopramide in tramadol-treated patients, suggesting a need to educate ETD medical officers on the findings to implement change in the routine prescribing practice in HTAN and subsequent cluster hospitals. Keywords: metoclopramide, tramadol, nausea, vomiting, emesis, prophylaxis. Title: Prophylactic Intravenous Metoclopramide Use in Patients Given Intravenous Tramadol: A Retrospective Cross-Sectional Study [TRAMAX STUDY] Author: Keerthy Venthen Krishna Kumar, Yu Xin Tan, Pavithrah Asogan International Journal of Healthcare Sciences ISSN 2348-5728 (Online) Vol. 13, Issue 1, April 2025 - September 2025 Page No: 44-48 Research Publish Journals Website: www.researchpublish.com Published Date: 23-April-2025 DOI: https://doi.org/10.5281/zenodo.15267834 Paper Download Link (Source) https://www.researchpublish.com/papers/prophylactic-intravenous-metoclopramide-use-in-patients-given-intravenous-tramadol-a-retrospective-cross-sectional-study-tramax-study

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 38%
Nausea and vomiting management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.